Cargando…
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors
Novel primaquine (PQ) and halogenaniline asymmetric fumardiamides 4a–f, potential Michael acceptors, and their reduced analogues succindiamides 5a–f were prepared by simple three-step reactions: coupling reaction between PQ and mono-ethyl fumarate (1a) or mono-methyl succinate (1b), hydrolysis of PQ...
Autores principales: | Rajić, Zrinka, Beus, Maja, Michnová, Hana, Vlainić, Josipa, Persoons, Leentje, Kosalec, Ivan, Jampílek, Josef, Schols, Dominique, Keser, Toma, Zorc, Branka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100582/ https://www.ncbi.nlm.nih.gov/pubmed/30011922 http://dx.doi.org/10.3390/molecules23071724 |
Ejemplares similares
-
Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents
por: Beus, Maja, et al.
Publicado: (2019) -
Primaquine derivatives: Modifications of the terminal amino group
por: Zorc, Branka, et al.
Publicado: (2019) -
Insights into biological activity of ureidoamides with primaquine and amino acid moieties
por: Vlainić, Josipa, et al.
Publicado: (2018) -
Itaconic acid hybrids as potential anticancer agents
por: Perković, Ivana, et al.
Publicado: (2020) -
SAHAquines, Novel Hybrids Based on SAHA and Primaquine Motifs, as Potential Cytostatic and Antiplasmodial Agents
por: Beus, Maja, et al.
Publicado: (2018)